HIV/AIDS Update - Kaletra (lopinavir/ritonavir) label update: drug interaction information
On January 17, 2013, FDA approved revisions to the Kaletra
(lopinavir/ritonavir) labels to include new drug interaction
information. The following updates were included.
Anticoagulants: Rivaroxaban. Avoid concomitant use of rivaroxaban
and Kaletra....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news